The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Abby R Rosenberg, MD, MS, MA
Dana-Farber Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama, Birmingham
Birmingham, Alabama, United States
- Children'S Hospital of Los Angeles
Los Angeles, California, United States
- Dana-Farber/harvard Cancer Center
Boston, Massachusetts, United States
- St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Seattle Children'S Hospital Cancer and Blood Disorders Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Apr 2019
- Primary completion
- 31 Mar 2023
- Completion
- 31 Mar 2024
- Last update posted
- 26 Oct 2024
- Registered enrollment
- 143
- Registry id
- NCT03640325
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.